Skip to main content
. 2020 Feb 21;15(4):577–584. doi: 10.2215/CJN.13291019

Figure 2.

Figure 2.

Dietary and pharmacologic-based strategies may target dysregulated metabolism in ADPKD. A summary is provided regarding whether dietary and pharmacologic-based strategies to potentially target dysregulated metabolism in ADPKD have been evaluated in nonpolycystic kidney disease (non-PKD) models (rodents and humans) and in PKD models (rodents and humans).